Submit Deal

EQT LIFE SCIENCES

HQ - Stockholm

Summary

EQT Life Sciences is a European investment firm focused on healthcare and life sciences, investing in innovative biotechnology, medical technology, and healthcare companies.

Deals Overview

Total Deals14

Valued Deals14

Total Value£ 2.63 B

Avg. Deal Size£ 188 M

Market Context

Parent Company

EQT PARTNERS

412 transactions

Senior Management

René Kuijten
CEO
Kim Henriksson
CFO
Arno de Wilde
Director

Sort

13 Jun 2022|France|Biotechnology

Target: IMCHECK THERAPEUTICS

Bidder: AGENT CAPITAL

16 Service Providers

3 Target | 13 Bidder

17 Dealmakers

3 Target | 14 Bidder

£ 91 M

Value

11 Oct 2023|Belgium|Biotechnology

Target: AGOMAB THERAUPETICS

Bidder: FIDELITY MANAGEMENT & RESEARCH COMPANY

4 Service Providers

2 Target | 2 Bidder

4 Dealmakers

2 Target | 2 Bidder

£ 81 M

Value

11 Oct 2023|Denmark|Biotechnology

Target: MINERVAX

Bidder: EQT LIFE SCIENCES

4 Service Providers

2 Target | 2 Bidder

5 Dealmakers

3 Target | 2 Bidder

£ 46 M

Value

13 Nov 2023|Netherlands|Biotechnology

Target: VECTORY

Bidder: MERCK & CO

6 Service Providers

2 Target | 4 Bidder

10 Dealmakers

5 Target | 5 Bidder

£ 112 M

Value

14 Mar 2024|France|Biotechnology

Target: AMOLYT PHARMA

Bidder: ASTRAZENECA PLC

12 Service Providers

7 Target | 2 Bidder | 3 Vendor

63 Dealmakers

23 Target | 35 Bidder | 5 Vendor

£ 820 M

Value

04 Mar 2024|Germany|Medical Services

Target: PHAGENESIS

Bidder: SECTORAL ASSET MANAGEMENT

3 Service Providers

2 Target | 1 Bidder

7 Dealmakers

6 Target | 1 Bidder

£ 33 M

Value

16 Jul 2024|Switzerland|Biotechnology

Target: ASCENEURON

Bidder: NOVO HOLDINGS AS

4 Service Providers

2 Target | 2 Bidder

10 Dealmakers

8 Target | 2 Bidder

£ 77 M

Value

14 Mar 2024|Germany|Biotechnology

Target: TUBULIS

Bidder: DEEP TRACK CAPITAL

4 Service Providers

2 Target | 2 Bidder

10 Dealmakers

7 Target | 3 Bidder

£ 109 M

Value

11 Dec 2024|Switzerland|Biotechnology

Target: NOEMA PHARMA

Bidder: EQT LIFE SCIENCES

5 Service Providers

4 Target | 1 Bidder

11 Dealmakers

10 Target | 1 Bidder

£ 24 M

Value

31 Oct 2024|United States|Biotechnology

Target: EVOMMUNE INC

Bidder: SYMBIOSIS

4 Service Providers

2 Target | 2 Bidder

3 Dealmakers

1 Target | 2 Bidder

£ 88 M

Value

11 Jun 2025|Spain|Pharmaceuticals

Target: SPLICEBIO

Bidder: UCB VENTURES

5 Service Providers

1 Target | 4 Bidder

9 Dealmakers

1 Target | 8 Bidder

£ 99 M

Value

24 Apr 2025|Netherlands|Biotechnology

Target: AVIDICURE

Bidder: EQT LIFE SCIENCES

7 Service Providers

2 Target | 5 Bidder

22 Dealmakers

15 Target | 7 Bidder

£ 42 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy